nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-EBE328C1·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.2 Clinical medicine·Subfield: Nutrition and Dietetics·Basis: Full text·Type: Observational cohort study

Clinical NEC prevention practices drive different microbiome profiles and functional responses in the preterm intestine.

Neumann et al.Neumann, Mahnert, Kumpitsch et al.·2023·Nature communications·10.1038/s41467-023-36825-1 ↗

Primary claim

We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants.

Tentative · center-confounded observational comparisons cannot establish regimen-driven resilience or reduced pathogenic threats
In brief

Multi-kingdom profiling maps preterm gut differences across three NICU regimens, but center-confounded treatment bundles prevent attribution to individual preventive practices.

ReliabilityCaveats4 of 4 checks completeRead the 3 entries ↓
Unlikely to hold — the claim's weakest requirement is that the effect exists at all. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

Preterm infants with very low birthweight are at serious risk for necrotizing enterocolitis. To functionally analyse the principles of three successful preventive NEC regimens, we characterize fecal samples of 55 infants (<1500 g, n = 383, female = 22) longitudinally (two weeks) with respect to gut microbiome profiles (bacteria, archaea, fungi, viruses; targeted 16S rRNA gene sequencing and shotgun metagenomics), microbial function, virulence factors, antibiotic resistances and metabolic profiles, including human milk oligosaccharides (HMOs) and short-chain fatty acids (German Registry of Clinical Trials, No.: DRKS00009290). Regimens including probiotic Bifidobacterium longum subsp. infantis NCDO 2203 supplementation affect microbiome development globally, pointing toward the genomic potential to convert HMOs. Engraftment of NCDO 2203 is associated with a substantial reduction of microbiome-associated antibiotic resistance as compared to regimens using probiotic Lactobacillus rhamnosus LCR 35 or no supplementation. Crucially, the beneficial effects of Bifidobacterium longum subsp. infantis NCDO 2203 supplementation depends on simultaneous feeding with HMOs. We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants.

Key Claims

Primary finding · Tentative

We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants.

Unlikely to hold — the claim's weakest requirement is that the effect exists at all. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

center-confounded observational comparisons cannot establish regimen-driven resilience or reduced pathogenic threats

Abstract
Quote verified
Secondary · Tentative

Engraftment of [Bifidobacterium longum subsp. infantis] NCDO 2203 is associated with a substantial reduction of microbiome-associated antibiotic resistance as compared to regimens using probiotic Lactobacillus rhamnosus LCR 35 or no supplementation.

bundled gentamicin exposure and unnormalized genomic hits limit interpretation of the observed resistance contrast

Abstract
Quote verified
Secondary · Tentative

Crucially, the beneficial effects of Bifidobacterium longum subsp. infantis NCDO 2203 supplementation depends on simultaneous feeding with HMOs.

no comparison isolates simultaneous probiotic and HMO feeding to establish the asserted dependence

Abstract
Quote verified
Secondary · Supported

Although both probiotic species, B. infantis NCDO 2203 and L. acidophilus NCDO 1748, were administered in equal amounts in K, L. acidophilus NCDO 1748 was substantially lower in abundance than the predominant B. infantis NCDO 2203

the within-Klagenfurt relative-abundance comparison directly documents unequal abundance despite equal administered doses

Results, paragraph 8
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Integrated profiling extends the cohort resource

Bacterial, archaeal, fungal and viral profiles are combined with functional metagenomics and NMR metabolomics. These measurements extend the cohort's earlier bacteriome analysis with genomic and metabolic descriptions.

↳ Methods, Sample processing; Results, Figs. 1–5

#methodological rigour

Contamination controls and genomic strain confirmation

The workflow includes 16 negative controls, decontam filtering and multiple MAG quality checks. Sequence and genome comparisons support identification of the administered probiotic strains in stool.

↳ Methods, DNA extraction, sequencing, and metabolomics

#positioning

Discussion explicitly identifies major interpretive limits

The Discussion states that changing treatment components cannot be disentangled and that iRep cannot establish colonization. It also acknowledges the small cohort, short observation period and low biomass of early samples.

↳ Discussion, iRep interpretation and limitations

Limitations

#methodological rigour

Treatment bundles remain inseparable from centers

Each NICU uses a different combination of probiotics, gentamicin, antifungals and feeding. The analysis cannot distinguish probiotic effects from these co-varying exposures, including the absence of gentamicin at the center with fewer resistance-gene hits.

↳ Table 1; Results, opening PERMANOVA analysis and resistance analysis; Discussion, limitations

#methodological rigour

Causal and synergy claims exceed comparisons

The Abstract asserts HMO-dependent probiotic benefit and regimen-driven ecosystem resilience. No group directly tests the probiotic-plus-predominantly-human-milk combination, and the observational center contrasts do not establish those causal effects.

↳ Abstract; Table 1; Discussion, HMO interpretation

#reporting

Virulence statement reverses its reported totals

The Results describe fewer pathogenic factors in Klagenfurt while reporting 193 hits there, versus 64 in Graz and 173 in Leoben. Klagenfurt therefore has the highest aggregate count, although normalized per-infant burden cannot be determined from these totals.

↳ Results, virulence-factor analysis; Fig. 5d

Does this match your read? Add your assessment ↓

Nabu Commentary

The multi-kingdom sequencing and NMR measurements provide a descriptive extension of the previously analyzed cohort. Prospective sampling, contamination controls and genomic strain confirmation support that descriptive use, but Table 1 shows that treatment components change together with NICU center. The Abstract's HMO-dependence and ecosystem-resilience claims therefore exceed the comparisons, while unnormalized resistance hits and the restricted metagenomic subset add uncertainty. The Discussion identifies the central design limitations, but the Results' reversed virulence-count statement and inaccurate significance summaries reduce reporting clarity.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.7±0.1

Contribution
3.4

Shotgun metagenomics, multi-kingdom profiling and NMR metabolomics extend an earlier bacteriome analysis of this cohort. The advance is principally descriptive, with functional comparisons concentrated in 23 tp7 samples and no separation of individual regimen components.

Methods, Sample processing; Results, Figs. 1–5
Methodological Rigour
1.8

Prospective collection, contamination filtering and genome-level strain confirmation support descriptive profiling, but center-confounded bundles and unsupported HMO-dependence claims substantially undermine intervention inference. Unnormalized resistance hits, unexamined metagenomic subset selection and the contradictory virulence-count statement add limitations, with the latter also surfaced through the Red reliability flag.

Table 1; Methods, Sample processing and Statistics & reproducibility; Abstract; Results, resistance and virulence analysis
Reporting
3.0

The progression from microbial composition to functional profiles and metabolites is followable. Text-versus-number contradictions in virulence and significance reporting, alongside incorrect figure references, reduce reporting precision.

Results, human milk and HMO conversion; Results, virulence-factor analysis; Figs. 1d and 4a
Positioning
3.6

The Introduction and Discussion engage with probiotic colonization, HMO metabolism and competing considerations around enteral antibiotics. The Discussion explicitly acknowledges confounding, short follow-up, low biomass and iRep limitations, although their quantitative implications receive less analysis.

Introduction; Discussion, iRep interpretation, antibiotic discussion and limitations

Lower confidence on Contribution — domain match limited.

Reliability

Caveats4 of 4 checks


Results checkNoted
  • We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants: "K infants had fewer pathogenic factors in their microbiomes than G and L infants" (Results, virulence factor analysis paragraph (Fig. 5d)) vs "G: 64 hits, K: 193 hits, L: 173 hits" (Results, virulence-factor analysis). The printed aggregate K count of 193 exceeds both G's 64 and L's 173, contradicting the stated lower-count direction without establishing normalized per-infant comparisons. → Not supported by the paper's own data
Reporting and transparencyNoted

Ethics approval, parental consent, trial registration, and sequencing-data and code resources are declared. The supplied text contains a malformed Gibberella q-value and an incorrect HMO figure reference.

Ethics approval: declared · Data availability: declared · Code availability: declared

Reference IntegrityNoted

95 references in manuscript 84 of 87 checkable references found in an index 8 are books, websites or datasets — counted, but not index-checkable

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Reproductive health and childbirth · Neonatal disorders
Type of advanceEmpirical
Route to useSpecified
AdvanceExtends
BeneficiariesLarge
CitationsFWCI 6.0
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessPiloted
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The claim rests on one prospective pilot cohort of 55 VLBW infants across three NICUs, with acknowledged center-level confounding and no independent confirmation.

From the paper
“combination of feeding HM and administering B. infantis NCDO 2203 during the first weeks of life in VLBW infants could be a promising synergistic approach”

The paper names the NICU decision and how: give VLBW infants human milk together with B. infantis NCDO 2203 during their first weeks of life, as a protocol improvement.

Pathway

Neonatologists and NICUs could revise NEC prophylaxis protocols to pair B. infantis NCDO 2203 supplementation with human milk feeding for VLBW preterm infants.

Barrier

The observational design confounds probiotics, antibiotics and feeding, so controlled trials are needed to isolate each component's effect before NICUs change protocols.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Human Milk Oligosaccharides in Maternal Serum Respond to Oral Glucose Load and Are Associated with Insulin Sensitivity

    Weiser-Fuchs, Maggauer, van Poppel, et al. · 2023 · Health sciences

    Primary claim

    Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered.

    Tentative
    Evidence Score
    2.8±0.1
    Reliability
    Caveats
  2. Hospital Regimens Including Probiotics Guide the Individual Development of the Gut Microbiome of Very Low Birth Weight Infants in the First Two Weeks of Life

    Kurath-Koller, Neumann, Moissl-Eichinger, et al. · 2020 · Clinical medicine

    Primary claim

    We found that hospital regimens significantly influenced the microbiome composition, diversity and quantity right from the beginning and all the way up to the more mature microbiome starting from two to three weeks of age onwards.

    Tentative
    Evidence Score
    2.5±0.1
    Reliability
    Caveats
  3. Maternal C-Peptide and Insulin Sensitivity, but Not BMI, Associate with Fatty Acids in the First Trimester of Pregnancy

    Bandres-Meriz, Majali-Martinez, Hoch, et al. · 2021 · Clinical medicine

    Primary claim

    Pregnant women (week 4+0–11+6) with a high C-peptide concentration and low insulin sensitivity (ISHOMA) had decreased serum concentration of total n-3 PUFA

    Supported
    Evidence Score
    3.2±0.2
    Reliability
    Caveats

How the rubric works →